[Joint effect of birth weight and obesity measures on abnormal glucose metabolism at adulthood]

Bo Xi1, Hong Cheng, Fangfang Chen

  • 1Department of Epidemiology, School of Public Health, Shandong University, Jinan 250012, China. #Department of Epidemiology, Capital Institute of Pediatrics, Beijing 100020, China.

Insights

Low birth weight combined with adult obesity significantly increases the risk of abnormal glucose metabolism. Controlling adult obesity is crucial to mitigate long-term health risks associated with birth weight.

Area of Science:

  • Endocrinology
  • Metabolic Health
  • Public Health

Background:

  • Birth weight is a critical factor influencing long-term health outcomes.
  • Obesity, particularly central obesity, is a growing global health concern.
  • Understanding the interplay between early-life factors and adult metabolic health is vital for preventative strategies.

Purpose of the Study:

  • To examine the combined impact of birth weight and adult obesity measures (BMI and waist circumference) on abnormal glucose metabolism.
  • To identify specific risk profiles associated with different birth weight categories and obesity levels.

Main Methods:

  • Historical cohort study design involving 972 adults followed up from infancy.
  • Data collected on birth weight, body mass index (BMI), waist circumference (WC), and glucose metabolism markers.
  • Statistical analyses including logistic regression and stratification to assess joint effects.

Main Results:

  • Low birth weight was associated with higher 2-hour plasma glucose levels in adulthood.
  • Adult overweight/obesity (BMI) increased the risk of abnormal glucose metabolism by 2.73 times.
  • Central obesity (WC) increased the risk by 3.35 times.
  • The highest risk for abnormal glucose metabolism was observed in individuals with low birth weight and adult overweight/obesity (OR=4.70) or central obesity (OR=4.78).
  • Significant interaction effects were found between low birth weight and adult obesity, and between high birth weight and central obesity.

Conclusions:

  • A strong interaction exists between birth weight and adult obesity (especially central obesity) in relation to abnormal glucose metabolism.
  • Preventative measures targeting adult obesity are essential to counteract the long-term health risks linked to birth weight.
  • Early life factors and adult lifestyle choices significantly influence metabolic health trajectories.
Abstract

Related Concept Videos

Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.5K
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
4.3K
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
5.5K
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
374
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
2.7K
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
281